Application of the Etest to the antimicrobial susceptibility testing of Mycobacterium marinum clinical isolates.

Application of the Etest to the antimicrobial susceptibility testing of Mycobacterium marinum clinical isolates. by Flynn CM, Kelley CM, Barrett MS and Jones RN published in J. Clin. Microbiol. 1997; 35 (8): 2083-2086

In vitro antimicrobial activity of RU-59863, a C-7 catechol substituted cephalosporin.

In vitro antimicrobial activity of RU-59863, a C-7 catechol substituted cephalosporin. by Erwin ME, Varnam D and Jones RN published in Diagn. Microbiol. Infect. Dis. 1997; 28 (2): 93-100

Multicenter laboratory evaluation of the bioMerieux Vitek antimicrobial susceptibility testing system with 11 antimicrobial agents versus members of the family Enterobacteriaceae and Pseudomonas aeruginosa.

Multicenter laboratory evaluation of the bioMerieux Vitek antimicrobial susceptibility testing system with 11 antimicrobial agents versus members of the family Enterobacteriaceae and Pseudomonas aeruginosa. by Doern GV, Brueggemann AB, Perla R, Daly J, Halkias D, Jones RN and Saubolle MA published in J. Clin. Microbiol. 1997; 35 (8): 2115-2119

A cluster of serious Escherichia coli infections in a neonatal intensive care unit.

A cluster of serious Escherichia coli infections in a neonatal intensive care unit. by Diekema DJ, Barr J, Boyken LD, Buschelman BJ, Jones RN, Pfaller MA and Herwaldt LA published in Infect. Control Hosp. Epidemiol. 1997; 18 (11): 774-776

Antimicrobial activity and spectrum of LB20304, a novel fluoronaphthyridone.

Antimicrobial activity and spectrum of LB20304, a novel fluoronaphthyridone. by Cormican MG and Jones RN published in Antimicrob. Agents Chemother. 1997; 41 (1): 204-211

Avoparcin, a glycopeptide used in animal foods: Antimicrobial spectrum and potency tested against human isolates from the United States.

Avoparcin, a glycopeptide used in animal foods: Antimicrobial spectrum and potency tested against human isolates from the United States. by Cormican MG, Erwin ME and Jones RN published in Diagn. Microbiol. Infect. Dis. 1997; 29 (4): 241-248

Validation of Etest for seven antimicrobial agents using regulatory criteria for the assessment of antimicrobial susceptibility devices.

Validation of Etest for seven antimicrobial agents using regulatory criteria for the assessment of antimicrobial susceptibility devices. by Biedenbach DJ, Schermer IH and Jones RN published in Diagn. Microbiol. Infect. Dis. 1997; 27 (1-2): 1-5

Disk diffusion test interpretive criteria and quality control recommendations for testing linezolid (U-100766) and eperezolid (U-100592) with commercially prepared reagents.

Disk diffusion test interpretive criteria and quality control recommendations for testing linezolid (U-100766) and eperezolid (U-100592) with commercially prepared reagents. by Biedenbach DJ and Jones RN published in J. Clin. Microbiol. 1997; 35 (12): 3198-3202

Comparative in vitro assessment of sparfloxacin activity and spectrum using results from over 14,000 pathogens isolated at 190 medical centers in the USA. SPAR Study Group.

Comparative in vitro assessment of sparfloxacin activity and spectrum using results from over 14,000 pathogens isolated at 190 medical centers in the USA. SPAR Study Group. by Ballow CH, Jones RN, Johnson DM, Deinhart JA, and Schentag JJ published in Diagn. Microbiol. Infect. Dis. 1997; 29 (3): 173-186

Impact of changing pathogens and antimicrobial susceptibility patterns in the treatment of serious infections in hospitalized patients.

Impact of changing pathogens and antimicrobial susceptibility patterns in the treatment of serious infections in hospitalized patients. by Jones RN published in Am. J. Med. 1996; 100 (6A): 3S-12S